Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Baena, Miguel ^a   Sangüesa, Gemma ^a   Dávalos, Alberto ^b   Latasa, María Jesús ^b   Sala Vila, Aleix ^c,d   Sánchez, Rosa María ^a,c   Roglans, Núria ^a,c   Laguna, Juan Carlos ^a,c   Alegret, Marta ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CSIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSE; GLUCOSE; INSULIN; SWEETENING AGENT;

ADIPOSE TISSUE; ANIMAL; CHEMICALLY INDUCED; DIET; FATTY LIVER; GLUCOSE TOLERANCE TEST; LIVER; METABOLISM; PATHOLOGY; PROCEDURES; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; DIET; FATTY LIVER; FRUCTOSE; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MUSCLE, SKELETAL; RATS; SIGNAL TRANSDUCTION; SWEETENING AGENTS;

EID: 84969932185     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26149     Document Type: Article

References (52)

1. Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat. Rev. Endocrinol. 8, 228-236 (2011).
2. Havel, P. J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr. Rev. 63, 133-157 (2005).
3. Stanhope, K. L. et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increase visceral adiposity and lipids and decrease insulin sensitivity in overweight/obese men. J. Clin. Invest. 1334, 1322-1334 (2009).
4. Alegret, M., Roglans, N. & Laguna, J. C. Fructose consumption and leptin resistance: what have we learnt from animal studies in Leptin: Hormonal Fuctions, Dysfunctions and Clinical Uses (eds. Hemling, R. M. et al.) 209-230 (Nova Science Publishers, 2011).
5. Vartanian, L. R., Schwartz, M. B. & Brownell, K. D. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am. J. Public Health 97, 667-75 (2007).
6. Goran, M. I. et al. The obesogenic effect of high fructose exposure during early development. Nat. Rev. Endocrinol. 9, 494-500 (2013).
7. O'Connor, L. et al. Prospective associations and population impact of sweet beverage intake and type 2 diabetes, and effects of substitutions with alternative beverages. Diabetologia 58, 1474-1483 (2015).
8. Sievenpiper, J. L. et al. Fructose vs. glucose and metabolism: do the metabolic differences matter? Curr. Opin. Lipidol. 25, 8-19 (2014).
9. Tappy, L., Lê, K. A., Tran, C. & Paquot, N. Fructose and metabolic diseases: new findings, new questions. Nutrition 26, 1044-1049 (2010).
10. Vilà, L. et al. Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J. Nutr. Biochem. 22, 741-51 (2011).
11. Rebollo, A. et al. Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats. J. Nutr. Biochem. 25, 250-258 (2014).
12. Sengupta, P. The laboratory rat: relating age with human's. Int J Prev Med 4, 624-630 (2013).
13. Benhamed, F. et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 122, 2176-2194 (2012).
14. Baena, M. et al. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress. Biochim. Biophys. Acta - Mol. Cell Biol. Lipids 1851, 107-116 (2015).
15. Roglans, N. et al. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45, 778-788 (2007).
16. Elias, I. et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes 61, 1801-1813 (2012).
17. Roglans, N. et al. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. J. Pharmacol. Exp. Ther. 302, 232-239 (2002).
18. Burdge, G. C., Wright, P., Jones, A. E. & Wootton, S. A. A method for separation of phosphatidylcholine, triacylglycerol, nonesterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br. J. Nutr. 84, 781-787 (2000).
19. Peter, A. et al. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin. Chem. 55, 2113-2120 (2009).
20. Dweep, H., Sticht, C., Pandey, P. & Gretz, N. MiRWalk - Database: Prediction of possible miRNA binding sites by 'walking' the genes of three genomes. J. Biomed. Inform. 44, 839-847 (2011).
21. Hsu, S.-D. et al. MiRTarBase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39, 163-169 (2011).
22. Helenius, M., Hänninen, M., Lehtinen, S. K. & Salminen, A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J. Mol. Cell. Cardiol. 28, 487-498 (1996).
23. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem 72, 248-254 (1976).
24. Nishiumi, S. & Ashida, H. Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci. Biotechnol. Biochem. 71, 2343-2346 (2007).
25. Yue, Y. et al. A central role for the mammalian target of rapamycin in LPS-induced anorexia in mice. J. Endocrinol. 224, 37-47 (2015).
26. 2- dependent cell migration via FoxO1 and CREB phosphorylation and translocation. Br. J. Pharmacol. 172, 5360-5376 (2015).
27. Vilà, L. et al. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 48, 1506-1516 (2008).
28. Vilà, L. et al. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol. Appl. Pharmacol. 251, 32-40 (2011).
29. Rebollo, A. et al. Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells. Biochim. Biophys. Acta 1841, 514-524 (2014).
30. Huang, D. et al. Fructose impairs glucose-induced hepatic triglyceride synthesis. Lipids Health Dis. 10, 20 (2011).
31. Ouyang, X. et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48, 993-999 (2008).
32. Lê, K. A. et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 89, 1760-1765 (2009).
33. Abdelmalek, M. F. et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961-1971 (2010).
34. Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788 (2010).
35. Hodson, L. & Fielding, B. A. Stearoyl-CoA desaturase: rogue or innocent bystander? Prog. Lipid Res. 52, 15-42 (2013).
36. Silbernagel, G., Machann, J., Häring, H.-U., Fritsche, A. & Peter, A. Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur. J. Clin. Nutr. 68, 97-100 (2013).
37. Pawar, A. & Jump, D. B. Unsaturated fatty fcid regulation of peroxisome proliferator-activated receptor activity in rat primary hepatoctes. J. Biol. Chem. 278, 35931-35939 (2003).
38. Bergheim, I. et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48, 983-992 (2008).
39. Spruss, A. et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50, 1094-1104 (2009).
40. Goedeke, L. et al. A regulatory role for microRNA 33∗ in controlling lipid metabolism gene expression. Mol. Cell. Biol. 33, 2339-2352 (2013).
41. McCann, S. E. et al. Reduction of dietary glycaemic load modifies the expression of microRNA potentially associated with energy balance and cancer pathways in pre-menopausal women. Br. J. Nutr. 109, 585-588 (2013).
42. Alisi, A. et al. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab. Invest. 91, 283-293 (2011).
43. Karpe, F., Dickmann, J. R. & Frayn, K. N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60, 2441-2449 (2011).
44. Nielsen, T. S., Jessen, N., Jorgensen, J. O. L., Moller, N. & Lund, S. Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J. Mol. Endocrinol. 52, R199-R222 (2014).
45. Crescenzo, R. et al. Adipose tissue remodeling in rats exhibiting fructose-induced obesity. Eur. J. Nutr. 53, 413-419 (2013).
46. Jia, G., Aroor, A. R., Martinez-Lemus, L. A. & Sowers, J. R. Overnutrition, mTOR signaling, and cardiovascular diseases. AJP Regul. Integr. Comp. Physiol. 307, R1198-R1206 (2014).
47. DeFronzo, R. A. & Tripathy, D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32 Suppl 2, S157-S163 (2009).
48. Sakamoto, K. & Holman, G. D. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol. Metab. 295, E29-E37 (2008).
49. Li, P. et al. A high-fructose diet impairs Akt and PKCζ phosphorylation and GLUT4 translocation in rat skeletal muscle. Horm. Metab. Res. 40, 528-532 (2008).
50. Faeh, D. et al. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 54, 1907-1913 (2005).
51. Lê, K. A. et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 84, 1374-1379 (2006).
52. Aeberli, I. et al. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care 36, 150-156 (2013).